Login
Home
Charts
Search
Watchlist
Products

Zydus Lifesciences Ltd

ZYDUSLIFE·NSE
₹1,162.30+0.11%Tue, 22 Sept '26 15:58
Industry:Pharma - Formulators
Indices:

Zydus Lifesciences Ltd

ZYDUSLIFE
NSE
₹1,162.30
+0.11%
|Tue, 22 Sept '26 15:58
SOICxStockScans Reports
Industry
Pharma - Formulators
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹1,15,940Cr
Close
Close Price
₹1,162.30
Industry
Industry
Pharma - Formulators
PE
Price To Earnings
25.90
PS
Price To Sales
4.06
Revenue
Revenue
₹28,592Cr
Rev Gr TTM
Revenue Growth TTM
21.11%
PAT Gr TTM
PAT Growth TTM
-3.14%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
4,3694,5055,5346,2085,2375,2696,5286,5746,1236,8657,5878,017
Growth YoY
Revenue Growth YoY%
5.75.810.420.819.917.018.05.916.930.316.222.0
Expenses
ExpensesCr
3,2233,4033,9034,1243,7763,8824,4024,4854,1075,0485,0336,088
Operating Profit
Operating ProfitCr
1,1461,1021,6312,0841,4611,3882,1262,0892,0161,8162,5541,929
OPM
OPM%
26.224.529.533.627.926.332.631.832.926.533.724.1
Other Income
Other IncomeCr
5438156636858-1391557527-26388
Interest Expense
Interest ExpenseCr
920353225327785101130123156
Depreciation
DepreciationCr
184195205215234229238238302360508555
PBT
PBTCr
1,0079261,5471,9001,2711,1841,6721,9211,6871,3531,6601,307
Tax
TaxCr
226214321436373180423434454388318354
PAT
PATCr
7807341,2291,4648981,0041,2491,4871,2339651,341952
Growth YoY
PAT Growth YoY%
52.525.3254.831.615.236.91.61.637.3-3.97.4-35.9
NPM
NPM%
17.916.322.223.617.119.119.122.620.114.117.711.9
EPS
EPS₹
7.97.811.714.19.110.211.614.612.510.412.79.3
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
4,3694,5055,5346,2085,2375,2696,5286,5746,1236,8657,5878,017
Growth YoY
Revenue Growth YoY%
5.75.810.420.819.917.018.05.916.930.316.222.0
Expenses
ExpensesCr
3,2233,4033,9034,1243,7763,8824,4024,4854,1075,0485,0336,088
Operating Profit
Operating ProfitCr
1,1461,1021,6312,0841,4611,3882,1262,0892,0161,8162,5541,929
OPM
OPM%
26.224.529.533.627.926.332.631.832.926.533.724.1
Other Income
Other IncomeCr
5438156636858-1391557527-26388
Interest Expense
Interest ExpenseCr
920353225327785101130123156
Depreciation
DepreciationCr
184195205215234229238238302360508555
PBT
PBTCr
1,0079261,5471,9001,2711,1841,6721,9211,6871,3531,6601,307
Tax
TaxCr
226214321436373180423434454388318354
PAT
PATCr
7807341,2291,4648981,0041,2491,4871,2339651,341952
Growth YoY
PAT Growth YoY%
52.525.3254.831.615.236.91.61.637.3-3.97.4-35.9
NPM
NPM%
17.916.322.223.617.119.119.122.620.114.117.711.9
EPS
EPS₹
7.97.811.714.19.110.211.614.612.510.412.79.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
9,4279,37711,90513,16614,25314,40415,11017,23719,54723,24227,14828,592
Growth
Revenue Growth%
9.0-0.527.010.68.31.14.914.113.418.916.821.1
Expenses
ExpensesCr
7,0967,4729,05710,18211,47011,01611,76913,37814,16316,18318,67320,276
Operating Profit
Operating ProfitCr
2,3311,9042,8482,9842,7833,3873,3413,8605,3847,0598,4758,316
OPM
OPM%
24.720.323.922.719.523.522.122.427.530.431.229.1
Other Income
Other IncomeCr
113128113191-250-160337-41827050-7-74
Interest Expense
Interest ExpenseCr
53459119434215912713081166439510
Depreciation
DepreciationCr
2923735395996976707137237649161,4081,725
PBT
PBTCr
2,0991,6152,3312,3821,4952,3992,8382,5904,8096,0276,6216,007
Tax
TaxCr
1771295645303201945125889781,4121,5951,515
PAT
PATCr
1,9211,4861,7661,8521,1762,2062,3262,0023,8314,6155,0264,492
Growth
PAT Growth%
62.0-22.718.94.8-36.587.65.5-13.991.420.48.9-3.1
NPM
NPM%
20.415.814.814.18.315.315.411.619.619.918.515.7
EPS
EPS₹
19.214.517.418.111.520.943.819.338.145.050.144.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
9,4279,37711,90513,16614,25314,40415,11017,23719,54723,24227,14828,592
Growth
Revenue Growth%
9.0-0.527.010.68.31.14.914.113.418.916.821.1
Expenses
ExpensesCr
7,0967,4729,05710,18211,47011,01611,76913,37814,16316,18318,67320,276
Operating Profit
Operating ProfitCr
2,3311,9042,8482,9842,7833,3873,3413,8605,3847,0598,4758,316
OPM
OPM%
24.720.323.922.719.523.522.122.427.530.431.229.1
Other Income
Other IncomeCr
113128113191-250-160337-41827050-7-74
Interest Expense
Interest ExpenseCr
53459119434215912713081166439510
Depreciation
DepreciationCr
2923735395996976707137237649161,4081,725
PBT
PBTCr
2,0991,6152,3312,3821,4952,3992,8382,5904,8096,0276,6216,007
Tax
TaxCr
1771295645303201945125889781,4121,5951,515
PAT
PATCr
1,9211,4861,7661,8521,1762,2062,3262,0023,8314,6155,0264,492
Growth
PAT Growth%
62.0-22.718.94.8-36.587.65.5-13.991.420.48.9-3.1
NPM
NPM%
20.415.814.814.18.315.315.411.619.619.918.515.7
EPS
EPS₹
19.214.517.418.111.520.943.819.338.145.050.144.9

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
102102102102102102102101101101101
Reserves
ReservesCr
5,5976,8588,64210,28410,27312,89016,89717,41519,72923,85327,011
Current Liabilities
Current LiabilitiesCr
3,4615,3066,0837,3438,2697,8617,8275,5275,3409,04215,712
Non Current Liabilities
Non Current LiabilitiesCr
1,2552,7993,0474,4613,7071,0949155411,8401,8027,113
Total Liabilities
Total LiabilitiesCr
10,55115,22118,06523,48323,68723,88527,79525,75629,28137,20252,407
Current Assets
Current AssetsCr
4,2806,0228,2308,4988,7158,71612,09510,00811,42017,04619,906
Non Current Assets
Non Current AssetsCr
6,2709,1989,83614,98514,97115,16915,70015,74817,86120,15632,501
Total Assets
Total AssetsCr
10,55115,22118,06523,48323,68723,88527,79525,75629,28137,20252,407
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
102102102102102102102101101101101
Reserves
ReservesCr
5,5976,8588,64210,28410,27312,89016,89717,41519,72923,85327,011
Current Liabilities
Current LiabilitiesCr
3,4615,3066,0837,3438,2697,8617,8275,5275,3409,04215,712
Non Current Liabilities
Non Current LiabilitiesCr
1,2552,7993,0474,4613,7071,0949155411,8401,8027,113
Total Liabilities
Total LiabilitiesCr
10,55115,22118,06523,48323,68723,88527,79525,75629,28137,20252,407
Current Assets
Current AssetsCr
4,2806,0228,2308,4988,7158,71612,09510,00811,42017,04619,906
Non Current Assets
Non Current AssetsCr
6,2709,1989,83614,98514,97115,16915,70015,74817,86120,15632,501
Total Assets
Total AssetsCr
10,55115,22118,06523,48323,68723,88527,79525,75629,28137,20252,407

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1,8941,3129191,2822,5053,2932,1042,6893,2286,7812,117
Investing Cash Flow
Investing Cash FlowCr
-864-2,872-974-4,239-1,012-7231,1541,171-1,475-8,358-8,296
Financing Cash Flow
Financing Cash FlowCr
-9352,316521,885-1,094-2,549-868-4,400-1,8101,9955,807
Net Cash Flow
Net Cash FlowCr
95756-3-1,072399222,390-540-58419-373
Free Cash Flow
Free Cash FlowCr
936-1,623-1162361,6172,4469371,6972,3455,139-530
CFO To PAT
CFO To PAT%
98.588.352.069.2213.1149.390.4134.384.3146.942.1
CFO To EBITDA
CFO To EBITDA%
81.368.932.343.090.097.263.069.760.096.125.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1,8941,3129191,2822,5053,2932,1042,6893,2286,7812,117
Investing Cash Flow
Investing Cash FlowCr
-864-2,872-974-4,239-1,012-7231,1541,171-1,475-8,358-8,296
Financing Cash Flow
Financing Cash FlowCr
-9352,316521,885-1,094-2,549-868-4,400-1,8101,9955,807
Net Cash Flow
Net Cash FlowCr
95756-3-1,072399222,390-540-58419-373
Free Cash Flow
Free Cash FlowCr
936-1,623-1162361,6172,4469371,6972,3455,139-530
CFO To PAT
CFO To PAT%
98.588.352.069.2213.1149.390.4134.384.3146.942.1
CFO To EBITDA
CFO To EBITDA%
81.368.932.343.090.097.263.069.760.096.125.0

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
32,44845,37738,76435,48327,34445,13235,69849,7501,01,15289,12287,6631,15,940
Price To Earnings
Price To Earnings
16.830.521.819.223.321.18.025.426.219.717.425.9
Price To Sales
Price To Sales
3.44.83.32.71.93.02.32.95.22.01.74.1
Price To Book
Price To Book
5.76.54.43.42.63.52.12.85.13.73.24.3
EV To EBITDA
EV To EBITDA
14.625.614.914.112.014.411.613.118.712.711.715.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
62.158.060.058.559.961.557.958.663.568.569.069.0
OPM
OPM%
24.720.323.922.719.523.522.122.427.530.431.229.1
NPM
NPM%
20.415.814.814.18.315.315.411.619.619.918.515.7
ROCE
ROCE%
27.613.917.514.710.614.514.014.523.722.817.817.8
ROE
ROE%
33.721.420.217.811.317.013.711.419.319.318.518.5
ROA
ROA%
18.29.89.87.95.09.28.47.813.112.49.69.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
32,44845,37738,76435,48327,34445,13235,69849,7501,01,15289,12287,6631,15,940
Price To Earnings
Price To Earnings
16.830.521.819.223.321.18.025.426.219.717.425.9
Price To Sales
Price To Sales
3.44.83.32.71.93.02.32.95.22.01.74.1
Price To Book
Price To Book
5.76.54.43.42.63.52.12.85.13.73.24.3
EV To EBITDA
EV To EBITDA
14.625.614.914.112.014.411.613.118.712.711.715.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
62.158.060.058.559.961.557.958.663.568.569.069.0
OPM
OPM%
24.720.323.922.719.523.522.122.427.530.431.229.1
NPM
NPM%
20.415.814.814.18.315.315.411.619.619.918.515.7
ROCE
ROCE%
27.613.917.514.710.614.514.014.523.722.817.817.8
ROE
ROE%
33.721.420.217.811.317.013.711.419.319.318.518.5
ROA
ROA%
18.29.89.87.95.09.28.47.813.112.49.69.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Zydus Lifesciences Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/txdvbgiz8c8j5c9gvq96csul.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/byyp3nq9kv8w9kqcjc9ztu0r.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/tnkoedquugss1jof9w9eriun.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/sg4k3t48sapxb4f3qxdkexqn.pdf
  • Q1 FY2026 Earnings Call Transcript (Jun 2025, PDF): https://www.stockscans.in/document/fbzbbf4iidfjf77yc0hdra0k.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/fv1fx2zncwda8l9902wc2dqg.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/59inbccu2x6thv3pedgz3dph.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/3ijhpb9me7pgu27iboyaszor.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/loamkgtvz89ue7it95uodxvf.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/tqdvzkkh6adfykbki1q6hz9w.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/bvdu13qfwhtus0acfrdxoh90.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/dr41kksm42sy4nn9u9q1pc97.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/ccxbywheerwmv256bq48az9u.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/nybds7do6wb4zp2iz928d30n.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/e7xdm1bgm03bx7z3ikatqi47.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/n4fnnvi9246saic5ss8qbtzs.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/9ulnvqxrnp2wy162qlwty4xf.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/rdbhq94gay5q2eh3dg9aiqsr.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/0zezvzgkrae4ezec849b6ecg.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/z7xe7uyp9sioetwtu1c0di24.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/g7n3fqb5dtqy8p8n61suwujw.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/we6temm2q6hpnu8azvx4x49s.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/o1os3ksxxnjge6rsmdjg1jfq.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/7djvnfagwlf303gztinx2iri.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/fkgu9lh2uybu07xyf5f2gmay.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/bqbm20vffkdef3isofqlj94w.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/11xtd5ylxmcw4yjmwld19afy.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/2lfwdnp989a9ai9mo1cgatjw.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/geq8125ahqskg8btoetsenm8.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/r4psite6txh9rh4b73lsmr7l.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/cdmbuv7j5ac074rpo2dlqdos.pdf

Concall Transcript Summaries — Zydus Lifesciences Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3AZYDUSLIFE/transcript-notes/202606/txdvbgiz8c8j5c9gvq96csul.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3AZYDUSLIFE/transcript-notes/202603/byyp3nq9kv8w9kqcjc9ztu0r.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3AZYDUSLIFE/transcript-notes/202512/tnkoedquugss1jof9w9eriun.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3AZYDUSLIFE/transcript-notes/202509/sg4k3t48sapxb4f3qxdkexqn.pdf
  • Q1 FY2026 Concall Transcript Summary (Jun 2025): https://www.stockscans.in/company/NSE%3AZYDUSLIFE/transcript-notes/202506/fbzbbf4iidfjf77yc0hdra0k.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3AZYDUSLIFE/transcript-notes/202503/fv1fx2zncwda8l9902wc2dqg.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3AZYDUSLIFE/transcript-notes/202412/59inbccu2x6thv3pedgz3dph.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3AZYDUSLIFE/transcript-notes/202409/3ijhpb9me7pgu27iboyaszor.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies